Drug delivery to the brain is extremely complicated. Researchers estimate that very little of therapeutic drugs make it beyond the blood-brain barrier and because of this, progress developing therapies for brain disease is very slow.
The researchers suggest more interdisciplinary research into drug delivery options that would bring together biologists, pharmaceutical scientists, and bioengineers.
'/>"/>
| Contact: Sara Buss buss@umn.edu 612-626-7037 University of Minnesota Source:Eurekalert |